These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20924829)

  • 1. Effect of changing antiretroviral treatment eligibility criteria on patient load in Kampala, Uganda.
    Konde-Lule J; Makumbi F; Pakker N; Muyinda A; Mubiru M; Cobelens FG
    AIDS Care; 2011 Jan; 23(1):35-41. PubMed ID: 20924829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
    Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
    AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda.
    Kagaayi J; Makumbi F; Nakigozi G; Wawer MJ; Gray RH; Serwadda D; Reynolds SJ
    AIDS; 2007 May; 21(9):1208-10. PubMed ID: 17502733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms.
    Nguyen RH; Gange SJ; Serwadda D; Kigozi G; Kiwanuka N; Sewankambo NK; Wabwire-Mangen F; Quinn TC; Wawer M; Gray RH
    Int J STD AIDS; 2006 Feb; 17(2):112-5. PubMed ID: 16464273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.
    Williams BG; Korenromp EL; Gouws E; Schmid GP; Auvert B; Dye C
    J Infect Dis; 2006 Nov; 194(10):1450-8. PubMed ID: 17054076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Between HIV diagnosis and initiation of antiretroviral therapy: assessing the effectiveness of care for people living with HIV in the public primary care service in Cape Town, South Africa.
    Scott V; Zweigenthal V; Jennings K
    Trop Med Int Health; 2011 Nov; 16(11):1384-91. PubMed ID: 21771213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in antiretroviral therapy guidelines: implications for public health policy and public purses.
    Hamilton A; Garcia-Calleja JM; Vitoria M; Gilks C; Souteyrand Y; De Cock K; Crowley S
    Sex Transm Infect; 2010 Oct; 86(5):388-90. PubMed ID: 20876757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
    Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-class HIV antiretroviral therapy failure in an Australian primary care setting.
    Bloch M; Farris M; Tilden D; Gowers A; Cunningham N
    Sex Health; 2010 Mar; 7(1):17-24. PubMed ID: 20152091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.